| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb Co (BMY) has 14 insiders with recent SEC Form 4 filings, including 3 buys and 3 sells. BMY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 204.7K | $11.54M | - | |
| CFO | 167.4K | $9.44M | - | |
| Dir | 66.1K | $3.73M | - | |
| Dir | 63.2K | $3.56M | - | |
| Dir | 38.9K | $2.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2019 | Bonney Michael W | Director | Buy | 88 | $58.90 | $5,183.20 | +1.2% | |
| Nov 5, 2019 | Schmukler Louis S | Pres., Global Mfg. &Supply | Sell | 25,000 | $56.56 | $1,414,000.00 | -43.9% | |
| Nov 5, 2019 | Elicker John E | SVP, Public Affairs &IR | Sell | 15,000 | $56.66 | $849,900.00 | -16.8% | |
| Jul 31, 2019 | Bertolini Robert J | Director | Buy | 11,000 | $44.72 | $491,920.00 | +2,771% | |
| May 16, 2019 | Santiago Karen Murphy | Controller | Sell | 3,065 | $47.56 | $145,771.40 | -50.0% | |
| May 16, 2019 | Samuels Theodore R. II51 | Director | Buy | 5,000 | $47.29 | $236,440.00 | +22.7% |